The co-expression characteristics of LAG3 and PD-1 on the T cells of patients with breast cancer reveal a new therapeutic strategy
Open Access
- 13 December 2019
- journal article
- research article
- Published by Elsevier BV in International Immunopharmacology
- Vol. 78, 106113
- https://doi.org/10.1016/j.intimp.2019.106113
Abstract
No abstract availableKeywords
Funding Information
- Fostering Foundation of the First Affiliated Hospital of Chongqing Medical University (PYJJ2017-26, PYJJ2018-05)
- Yuzhong District Science and Technology Project (20170408)
- Scientific Research Fund of Chongqing Medical University (NSFYY201705)
- joint scientific research project of Chongqing Science and Technology Commission and Health Commission (2019MSXM019)
This publication has 46 references indexed in Scilit:
- PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patientsBreast Cancer Research and Treatment, 2017
- An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancersBreast Cancer Research, 2016
- Cooperation of PD-1 and LAG-3 Contributes to T-Cell Exhaustion in Anaplasma marginale-Infected CattleInfection and Immunity, 2016
- Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancersBreast Cancer Research, 2016
- Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating LymphocytesCancer Immunology Research, 2016
- Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune TargetingClinical Medicine Insights: Oncology, 2016
- LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer modelOncotarget, 2015
- LAG3 Expression in Active Mycobacterium tuberculosis InfectionsThe American Journal of Pathology, 2014
- Clinical blockade of PD1 and LAG3 — potential mechanisms of actionNature Reviews Immunology, 2014
- SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell ActivationThe Journal of Immunology, 2004